stock logo
NIFTY PHARMA
₹22,153.80
+142.10 (0.65%)

Nifty Pharma (NIFTY PHARMA) live share price today at NSE

Overview
Charts
Stocks
Today`s low
0.00
Today`s high
0.00
Today`s return
View all

Nifty Pharma Index - A Brief Introduction

Nifty Pharma is a sector-specific index of the National Stock Exchange (NSE) of India. It consists of a maximum of 20 NSE-listed securities from the pharmaceutical and biotechnology industries. The Nifty Pharma index focuses on capturing the real-time performance and behaviour of the Indian pharmaceutical sector and provides useful insights to investors. 

The index was launched on the 1st January 2005 with a base value and base date of 1000 and 1st January 2001, respectively. The Nifty Pharma Index chart clearly depicts that the index has grown significantly, surpassing its base value by more than 200% over the period. 

The Nifty Pharma stock list includes listed securities such as Ipca Laboratories Ltd.,  J.B. Chemicals & Pharmaceuticals Ltd., Laurus Labs Ltd., Lupin Ltd., Mankind Pharma Ltd., NATCO Pharma Ltd., and many other securities representing the pharmaceutical and biotech industry of India. 


The NSE Indices Limited, a wholly owned subsidiary of the NSE, is responsible for owning and operating the Nifty indexes. This organisation launched the Nifty Pharma index, too, and currently undertakes the management and governance of the index. 

 

Nifty Pharma Index - Formula and Calculation

Nifty Pharma Index is calculated using the free-float market capitalisation method, wherein the index value represents the aggregate free-float market cap of all the constituents. Here, free float refers to the outstanding equity shares of a company that are available for trading on the secondary market. To know more about the calculation of the Nifty Pharma index, refer to the formula below: 

Nifty Pharma Index Formula - Current free-float market cap / (base market cap * base index value)

Here, 

Base index value = 1000

Free-float market cap = shares outstanding * IWF * capping factor * price 

IWF = Investible weight factor 

The Nifty Pharma index is subject to a semi-annual rebalancing, with cutoff dates being 31st January and 31st July each year. For this periodic rebalancing, the average data for six months ending on the cutoff dates is considered. 

 

Nifty Pharma Index Stocks - Eligibility Criteria

To become eligible for the Nifty Pharma, companies have to meet the following eligibility criteria set by the index committee: 

  1. The company must be domiciled in India and listed on the National Stock Exchange (NSE). 
  2. If stocks representing a sector within the Nifty 500 fall below 20, then the remaining stocks are selected from the top 800 based on the average daily turnover and average daily full market cap based on the data of the average of the previous six months.
  3. The companies must form part of the pharmaceutical sector and the Nifty 500 at the time of review. 
  4. In the last six months, the company’s trading frequency should be at least 90%. 
  5. As of the cutoff date, the company must have a minimum listing history of 1 month. 
  6. The final selection of 20 stocks is based on free-float market capitalisation. At the time of selection, stocks available for trading on F&O are given preference. 
  7. The weightage of each stock is capped at 33%, and the cumulative weightage of the top 3 stocks is capped at 62%. 

Nifty Pharma Index Historical Trend

Since its inception, the Nifty Pharma index has yielded over 13% price returns, with its total returns for the same period standing at 14.37%. For the last 1-year and 5-year duration, the index has given 14.08% and 17.03% price returns, respectively, against total returns of 14.82% and 17.84% for the same period. 

 

Key Takeaways on Nifty Pharma Index

  1. Nifty Pharma Index is a sector-focused index of the NSE, launched on 1st January 2005. 
  2. The index is designed to track and reflect the overall performance of India’s pharmaceutical sector. 
  3. It has a base value of 1000 and is constituted of 20 stocks from the pharmaceutical and biotechnology sectors. 
  4. The value of the Nifty Pharma index is calculated using the free-float market cap method. 

FAQs

Is Nifty Pharma a good investment?

arrow

Nifty Pharma has given double-digit price returns of more than 13% since its inception. It has also yielded ~14% price returns and ~14.8% total returns in the last 1 year. It indicates that the index has experienced significant growth in the long term.

How many stocks are there in Nifty Pharma?

arrow

The Nifty Pharma Index includes 20 NSE-listed pharma stocks. The top 5 Nifty Pharma stocks as per market weightage include:   Sun Pharmaceuticals Limited (23.74%) Divi’s Laboratories Limited (11.02%) Cipla Limited (10.82%) Dr Reddy Laboratories Limited (10.02%) Lupin Limited (6.21%) 

Which is the biggest pharma company in India?

arrow

Sun Pharmaceutical Limited is the largest pharma company in India with a market capitalisation of more than 4.00 lakh crores.  

How can I invest in Nifty Pharma?

arrow

You can invest in Nifty Pharma by directly investing in each of the 20 companies separately, which are included in the index. Also, you can choose a suitable Nifty Pharma ETF or index fund to invest in the index, with low risk and limited capital. 

icon

100% Safe & Secure Platform.

Univest encrypts all data and transactions to ensure a completely secure experience for our members.

Copyright

2025 Univest. All rights reserved. | Designed with ❤️ in India
About Univest
About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
 
Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
 
Univest Stock Broking Disclosures
Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
 Risk Disclosures on Derivatives
1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
2. On an average, loss makers registered net trading loss close to ₹ 50,000
3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
Investors are further cautioned to avoid practices like:
a. Sharing 
i) trading credentials – login id and passwords including OTPs.
ii) trading strategies,
iii) position details.
b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
 Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
General
arrow down